KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Invested Capital (2016 - 2025)

Historic Invested Capital for BeOne Medicines (ONC) over the last 11 years, with Q3 2025 value amounting to $4.3 billion.

  • BeOne Medicines' Invested Capital fell 72.05% to $4.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 billion, marking a year-over-year decrease of 72.05%. This contributed to the annual value of $3.5 billion for FY2024, which is 1720.4% down from last year.
  • Per BeOne Medicines' latest filing, its Invested Capital stood at $4.3 billion for Q3 2025, which was down 72.05% from $4.6 billion recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Invested Capital registered a high of $6.6 billion during Q4 2021, and its lowest value of $3.5 billion during Q4 2024.
  • For the 5-year period, BeOne Medicines' Invested Capital averaged around $4.6 billion, with its median value being $4.3 billion (2025).
  • As far as peak fluctuations go, BeOne Medicines' Invested Capital surged by 5710.37% in 2021, and later plummeted by 2864.13% in 2022.
  • Quarter analysis of 5 years shows BeOne Medicines' Invested Capital stood at $6.6 billion in 2021, then decreased by 28.64% to $4.7 billion in 2022, then fell by 9.73% to $4.2 billion in 2023, then decreased by 17.2% to $3.5 billion in 2024, then increased by 22.01% to $4.3 billion in 2025.
  • Its Invested Capital was $4.3 billion in Q3 2025, compared to $4.6 billion in Q2 2025 and $4.3 billion in Q1 2025.